The star of Monday’s deal is gusacitinib, a small-molecule drug that Formation is developing for chronic hand eczema. Sanofi ...

Having secured one of last year’s largest funding rounds, AI-focused Formation Bio is now eyeing up 545 million euros ($626 ...

Another notable valuation metric for PBH is its P/B ratio of 2.28. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total ...

We recently published a list of Jim Cramer Had These 21 Stocks on His Radar. In this article, we are going to take a look at where Stryker Corporation (NYSE:SYK) stands against other stocks that ...

PBH currently has a forward P/E ratio of 17.73, while SYK has a forward P/E of 28.63. We also note that PBH has a PEG ratio of 2.53. This popular figure is similar to the widely-used P/E ratio, ...

Below is Validea's guru fundamental report for STRYKER CORP (SYK). Of the 22 guru strategies we follow, SYK rates highest using our Multi-Factor Investor model based on the published strategy of ...

When a caller asked about Stryker Corporation (NYSE:SYK), Cramer replied: “I like Stryker, but you know, I don’t like it enough. I don’t like it as much as if it was Intuitive Surgical.

Climate Solutions A gene could be key to growing rice, and feeding billions, in a hotter world. Researchers say they can improve rice harvests and grain quality by essentially turning off a ...

Personalized gene editing saved a baby, but the tech’s future is uncertain. Costs, government regulation and lack of know-how could hinder wider use of the CRISPR tech ...